The clinical database and implementation of treatment guidelines by the Danish Breast Cancer Cooperative Group in 2007–2016

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Acta oncologica

• Publication date

  2018-01-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/0284186X.2017.1404638PMID 29202621
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An inter-observer Ki67 reproducibility study applying two different assessment methods: on behalf of the Danish Scientific Committee of Pathology, Danish breast cancer cooperative group (DBCG)

  2018cited by this paper
• PAM50 Risk of Recurrence Score Predicts 10-Year Distant Recurrence in a Comprehensive Danish Cohort of Postmenopausal Women Allocated to 5 Years of Endocrine Therapy for Hormone Receptor-Positive Early Breast Cancer.

  2018cited by this paper
• Adjuvant Pertuzumab and Trastuzumab in Early HER2‐Positive Breast Cancer

  2017cited by this paper
• years ’ follow-up of trastuzumab after adjuvant chemotherapy in HER 2-positive early breast cancer : fi nal analysis of the HERceptin Adjuvant ( HERA ) trial

  2017cited by this paper
• International variation in adherence to referral guidelines for suspected cancer: a secondary analysis of survey data.

  2016cited by this paper
• Improvements in breast cancer survival between 1995 and 2012 in Denmark: The importance of earlier diagnosis and adjuvant treatment

  2016cited by this paper
• Applying clinical guidelines in general practice: a qualitative study of potential complications

  2016cited by this paper
• DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer.

  2016cited by this paper
• Barriers and Strategies in Guideline Implementation—A Scoping Review

  2016cited by this paper
• Excess mortality in postmenopausal high-risk women who only receive adjuvant endocrine therapy for estrogen receptor positive breast cancer

  2014cited by this paper
• CT-planned internal mammary node radiotherapy in the DBCG-IMN study: Benefit versus potentially harmful effects

  2014cited by this paper
• The Danish Civil Registration System as a tool in epidemiology

  2014influential reference
• Quality assurance of conventional non-CT-based internal mammary lymph node irradiation in a prospective Danish Breast Cancer Cooperative Group trial: The DBCG-IMN study

  2013cited by this paper
• Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.

  2013cited by this paper
• Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.

  2013cited by this paper
• WHO classification of tumours of the breast

  2012cited by this paper
• Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark.

  2011cited by this paper
• Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.

  2011cited by this paper
• American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

  2010cited by this paper
• Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy.

  2010cited by this paper
• American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

  2010cited by this paper
• Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer.

  2009cited by this paper
• A history of health technology assessment at the European level

  2009cited by this paper
• The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise

  2008cited by this paper
• Danish Breast Cancer Cooperative Group – DBCG: History, organization, and status of scientific achievements at 30-year anniversary

  2008cited by this paper
• Improvement of prognosis in breast cancer in Denmark 1977–2006, based on the nationwide reporting to the DBCG Registry

  2008cited by this paper
• Factors influencing the implementation of clinical guidelines for health care professionals: A systematic meta-review

  2008cited by this paper
• Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trial.

  2008cited by this paper
• Classical pathological variables recorded in the Danish Breast Cancer Cooperative Group's register 1978–2006

  2008cited by this paper
• Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.

  2007cited by this paper
• Benefit of taxanes as adjuvant chemotherapy for early breast cancer

  2006cited by this paper
• American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

  2006cited by this paper
• Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

  2005cited by this paper
• A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer*

  2004cited by this paper
• Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands

  2004cited by this paper
• Translating guidelines into practice: a systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines

  1997cited by this paper
• Effect of Clinical Guidelines on Medical Practice: A Systematic Review of Rigorous Evaluations

  1994cited by this paper
• Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations.

  1993cited by this paper
• Danish Breast Cancer Cooperative Group (DBCG). A description of the register of the nation-wide programme for primary breast cancer.

  1988cited by this paper
• A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

  1987cited by this paper
• International Agency for Research on Cancer.

  1985cited by this paper

• Socioeconomic differences in labour market attachment after breast cancer: a population-based matched cohort study

  2026cites this paper
• Aromatase inhibitors, cardiovascular medications, and patient outcomes - Authors' reply.

  2025cites this paper
• Outcomes based on risk-adapted adjuvant therapy in postmenopausal women with early breast cancer: a nationwide, prospective cohort study by the Danish Breast Cancer Group.

  2025cites this paper
• 17β-Hydroxysteroid dehydrogenases 1 and 2: potential markers for breast cancer recurrence and tamoxifen resistance among premenopausal women diagnosed with breast cancer in Denmark

  2025cites this paper
• Time trends, uptake, and oncological effects of risk-reducing surgeries in 3067 Danish BRCA1/2 carriers: a population-based study with matched controls

  2025cites this paper
• Bilateral Risk‐Reducing Mastectomy With Immediate Breast Reconstruction Lowers Concerns of Breast Cancer in Women With a High‐Risk Genetic Predisposition for Breast Cancer Compared With a Radiological Imaging Surveillance Group

  2025cites this paper
• Changes in LDL-cholesterol levels following aromatase inhibitor treatment in early postmenopausal breast cancer

  2025cites this paper
• Prognostic Value of Pre-treatment Plasma C-Reactive Protein in Patients with Early-Stage Breast Cancer.

  2024cites this paper
• Internal mammary node irradiation in 4541 node-positive breast cancer patients treated with newer systemic therapies and 3D-based radiotherapy (DBCG IMN2): a prospective, nationwide, population-based cohort study

  2024cites this paper
• Trends in breast cancer among elderly women: Development in estrogen and HER2 subtypes in the last ten years

  2024cites this paper
• Survival outcomes for HER2-low breast cancer: Danish national data

  2024cites this paper
• Ischaemic cardiotoxicity of aromatase inhibitors in postmenopausal patients with early breast cancer in Denmark: a cohort study of real-world data.

  2024cites this paper
• Locoregional Lymph Node Metastasis from Clinically Occult Breast Cancer: Prognostic Significance of Mastectomy

  2024cites this paper
• Evaluating the Prognostic Role of the PAM50 Signature and Selected Immune-Related Signatures for Recurrence in Patients With T1abN0 Breast Cancer.

  2024cites this paper
• The Population-level Effect of Adjuvant Therapies on Breast Cancer Recurrence: Application of the Trend-in-Trend Design

  2024cites this paper
• Evaluating Danish Breast Cancer Group locoregional radiotherapy guideline adherence in clinical treatment data 2008-2016: The DBCG RT Nation study.

  2024cites this paper
• Capecitabine monotherapy as first-line treatment in advanced HER2-normal breast cancer – a nationwide, retrospective study

  2024cites this paper
• Social characteristics and social benefit use among premenopausal breast cancer survivors in Denmark: a population-based cohort study

  2024cites this paper
• Clinical factors associated with patterns of endocrine therapy adherence in premenopausal breast cancer patients

  2024cites this paper
• Development and Methodological Validation of a Modified Staging System for de Novo Metastatic Breast Cancer

  2024cites this paper
• Digital image analysis and assisted reading of the HER2 score display reduced concordance: pitfalls in the categorisation of HER2‐low breast cancer

  2023cites this paper
• High inter-laboratory variability in the assessment of HER2-low breast cancer: a national registry study on 50,714 Danish patients

  2023influential citation
• End-to-end framework for automated collection of large multicentre radiotherapy datasets demonstrated in a Danish Breast Cancer Group cohort

  2023cites this paper
• Histomorphologic Prognostic Factors in Invasive Breast Carcinoma-NST Affecting Loco-Regional Recurrence

  2023cites this paper
• Patient-Related Characteristics Associated with Treatment Modifications and Suboptimal Relative Dose Intensity of Neoadjuvant Chemotherapy in Patients with Breast Cancer—A Retrospective Study

  2023cites this paper
• The impact of single nucleotide polymorphisms on return-to-work after taxane-based chemotherapy in breast cancer

  2023cites this paper
• Management and outcomes after neoadjuvant treatment for locally advanced breast cancer in older versus younger women

  2022cites this paper
• Breast-Conserving Surgery or Mastectomy?

  2022cites this paper
• Adjuvant chemotherapy in patients with ER-negative/HER2-negative, T1abN0 breast cancer: a nationwide study

  2022influential citation
• The association between guideline adherence, age and overall survival among women with non-metastatic breast cancer: A systematic review.

  2022cites this paper
• Single-nucleotide polymorphisms and the effectiveness of taxane-based chemotherapy in premenopausal breast cancer: a population-based cohort study in Denmark

  2022cites this paper
• Benefit of adjuvant chemotherapy and trastuzumab in patients with HER2-positive, node-negative breast tumors ≤ 10 mm: a nationwide study

  2022cites this paper
• Diagnosis of bone metastases in breast cancer: Lesion-based sensitivity of dual-time-point FDG-PET/CT compared to low-dose CT and bone scintigraphy

  2021cites this paper
• Road and railway noise and risk for breast cancer: A nationwide study covering Denmark.

  2021cites this paper
• Risk of coronary artery disease after adjuvant radiotherapy in 29,662 early breast cancer patients: A population-based Danish Breast Cancer Group study.

  2021cites this paper
• The development and initial validation of the Breast Cancer Recurrence instrument (BreastCaRe)—a patient-reported outcome measure for detecting symptoms of recurrence after breast cancer

  2021cites this paper
• Socioeconomic position and prognosis in premenopausal breast cancer: a population-based cohort study in Denmark

  2021cites this paper
• Comparison of upper extremity lymphedema after sentinel lymph node biopsy and axillary lymph node dissection: patient-reported outcomes in 3044 patients

  2021cites this paper
• The Incidence of Breast Cancer Recurrence 10-32 Years After Primary Diagnosis

  2021cites this paper
• Hypoxia-inducible factor-1α expression and breast cancer recurrence in a Danish population-based case control study

  2021cites this paper
• Outcome reporting in therapeutic mammaplasty: a systematic review

  2021cites this paper
• University of Southern Denmark Adherence to treatment guidelines and survival in older women with early-stage breast cancer in Denmark 2008-2012 Vogsen,

  2020cites this paper
• Treatment variation in early breast cancer in the UK

  2020cites this paper
• Neoadjuvant chemotherapy and HER2 dual blockade including biosimilar trastuzumab (SB3) for HER2-positive early breast cancer: Population based real world data from the Danish Breast Cancer Group (DBCG)

  2020cites this paper
• Hypofractionated radiation therapy for breast cancer: preferences amongst radiation oncologists in europe - results from an international survey.

  2020cites this paper
• Association between early discontinuation of endocrine therapy and recurrence of breast cancer among premenopausal women in a Danish population-based cohort

  2020cites this paper
• Rates of re‐excision and conversion to mastectomy after breast‐conserving surgery with or without oncoplastic surgery: a nationwide population‐based study

  2020cites this paper
• Statin use and breast cancer recurrence in postmenopausal women treated with adjuvant aromatase inhibitors: a Danish population-based cohort study

  2020cites this paper
• Breast-contour preserving procedures for early-stage breast cancer: a population-based study of the trends, variation in practice and predictive characteristics in Denmark and the Netherlands

  2020cites this paper
• Tumour-infiltrating lymphocytes and response to neoadjuvant letrozole in patients with early oestrogen receptor-positive breast cancer: analysis from a nationwide phase II DBCG trial

  2020cites this paper
• Healthcare providers’ adherence to breast cancer guidelines in Europe: a systematic literature review

  2020cites this paper
• Adherence to treatment guidelines and survival in older women with early-stage breast cancer in Denmark 2008–2012

  2020cites this paper
• Predictive pharmacogenetic biomarkers for breast cancer recurrence prevention by simvastatin

  2020cites this paper
• The role of H1 antihistamines in contralateral breast cancer: a Danish nationwide cohort study

  2020cites this paper
• Metabolic Pathway Analysis and Effectiveness of Tamoxifen in Danish Breast Cancer Patients

  2020cites this paper
• Early Discontinuation of Endocrine Therapy and Recurrence of Breast Cancer among Premenopausal Women

  2020cites this paper
• The Assisi Think Tank Meeting Survey of post-mastectomy radiation therapy in ductal carcinoma in situ: Suggestions for routine practice.

  2019cites this paper
• Effect of progressive resistance training on persistent pain after axillary dissection in breast cancer: a randomized controlled trial

  2019cites this paper
• Sentinel and non-sentinel lymph node metastases in patients with microinvasive breast cancer: a nationwide study

  2019cites this paper
• Breast cancer mortality in synchronous bilateral breast cancer patients

  2019cites this paper
• Preventive drug therapy and contralateral breast cancer: summary of the evidence of clinical trials and observational studies

  2019cites this paper
• Oncoplastic Breast Surgery Compared to Conventional Breast-Conserving Surgery With Regard to Oncologic Outcome.

  2019cites this paper
• International Variation in Criteria for Internal Mammary Chain Radiotherapy

  2019cites this paper
• Low-dose aspirin use and risk of contralateral breast cancer: a Danish nationwide cohort study.

  2018cites this paper
• An Automated and Accurate Methodology to Assess Ki-67 Labeling Index of Immunohistochemical Staining Images of Breast Cancer Tissues

  2018cites this paper
• The potential benefits from respiratory gating for breast cancer patients regarding target coverage and dose to organs at risk when applying strict dose limits to the heart: results from the DBCG HYPO trial

  2018cites this paper
• Evaluation of Optical Surface Scanning of Breast Cancer Patients for Improved Radiotherapy

  2018influential citation
• Expression of survivin does not appear to influence breast cancer recurrence risk

  2018cites this paper
• Provision of data from the clinical database and of biological material from the tumor bank of the Danish Breast Cancer Cooperative Group 2008–2017

  2018cites this paper